Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications

Diabetic Medicine

Volumn 27, Issue 7, 2010, Pages 804-811

  Ayad, F ^a   Belhadj, M ^a   Paries J ^b   Attali, J R ^b   Valensi, P ^b  

^a CHU Oran   (Algeria)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

cardiac autonomic neuropathy; diabetes; hypertension; macrovascular complications; microangiopathy

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOSTATIC HYPOTENSION; RETINOPATHY; RISK FACTOR; STROKE; VASCULAR DISEASE;

ADULT; ALGERIA; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIABETIC NEUROPATHIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; ODDS RATIO; RISK FACTORS;

EID: 77954254360     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03027.x     Document Type: Article

References (29)

1. Ziegler D. Diabetic cardiovascular autonomic neuropathy. Prognosis, diagnosis and treatment. Diab Metab Rev 1994 10 : 339 383.
2. Vinik AL, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003 26 : 1553 1579. (Pubitemid 36934465)
3. Valensi P, Pariès J, Attali JR, the French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications- the French multicenter study. Metabolism 2003 52 : 815 820.
4. Maser RE, Mitchell BD, Vinik AL, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003 26 : 1895 1901.
5. Ewing DJ, Boland O, Neilson JM, Clo CG, Clarke BF. Autonomic neuropathy, QT-interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991 34 : 182 185.
6. Valensi P, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabetes Care 2002 25 : 918 923.
7. Valensi P, Sachs RN, Harfouche B, Lormeau B, Pariés J, Cosson E et al. Predictive value of cardiac autonomic neuropathy in diabetic patient with or without silent myocardial ischemia. Diabetes Care 2001 24 : 339 343.
8. Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB et al. Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy. Diabet Med. 2004 21 : 524 530.
9. Zola B, Kahn JK, Juni JE, Vinik AL. Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab 1986 63 : 208 224.
10. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998 32 : 293 297.
11. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989 14 : 177 183.
12. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension 2003 42 : 1106 1111.
13. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 1996 9 : 113S 120S.
14. Krolewski AS, Barzilay J, Warram JH, Martin BC, Pfeifer M, Rand LI. Risk of early onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy. Diabetes 1992 41 : 430 437.
15. Mølgaard H, Christensen PD, Sørensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992 41 : 812 817.
16. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993 16 : 773 779.
17. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994 17 : 578 584.
18. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 2001 24 : 1793 1798.
19. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005 28 : 956 962.
20. Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Med 1998 15 : 508 514.
21. Valensi P, Attali JR, Gagant S, the French Group for Research and Study of Diabetic Neuropathy. Reproductibility of parameters for assessment of diabetic neuropathy. Diabet Med 1993 10 : 933 939.
22. Witte DR, Tesfaye S, Chaturvedi N, Eaton SEM, Kempler P, Fuller JH, EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005 48 : 164 171.
23. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003 108 : 3097 3101.
24. Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998 97 : 2037 2042.
25. Johnson MD, Grignolo A. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci 1983 33 : 169 180.
26. Giannattasio C, Mancia G. Arterial distensibility in humans. Modulating mechanisms, alterations in diseases and effects of treatment. J Hypertens 2002 20 : 1889 1899.
27. Brahimi M, Dabire H, Platon P, Hadj-Brahim R, Attali JR, Valensi P. Arterial rigidity and cardiovascular vagosympathetic activity in normotensive and hypertensive obese patients and type 2 diabetes. Arch Mal Coeur 2001 94 : 944 946. (Pubitemid 34241966)
28. Airaksinen KE, Koistinen MJ, Ikäheimo MJ, Pirttiaho H, Huikuri HV, Takkunen JT. Effect of coronary artery disease on parasympathetic cardiovascular reflexes in NIDDM patients. Diabetes Care 1990 13 : 83 86.
29. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007 25 : 909 920.